APA (7th ed.) Citation

Li, X., Liu, L., Liu, F., Guo, Y., Chen, X., Zhu, X., & Yang, W. (2023). Safety and short-term effectiveness of blinatumomab in the treatment of childhood relapsed/refractory acute lymphoblastic leukemia. Zhongguo dang dai er ke za zhi, 25(4), 374. https://doi.org/10.7499/j.issn.1008-8830.2210114

Chicago Style (17th ed.) Citation

Li, Xiao-Lan, Li-Peng Liu, Fang Liu, Ye Guo, Xiao-Juan Chen, Xiao-Fan Zhu, and Wen-Yu Yang. "Safety and Short-term Effectiveness of Blinatumomab in the Treatment of Childhood Relapsed/refractory Acute Lymphoblastic Leukemia." Zhongguo Dang Dai Er Ke Za Zhi 25, no. 4 (2023): 374. https://doi.org/10.7499/j.issn.1008-8830.2210114.

MLA (9th ed.) Citation

Li, Xiao-Lan, et al. "Safety and Short-term Effectiveness of Blinatumomab in the Treatment of Childhood Relapsed/refractory Acute Lymphoblastic Leukemia." Zhongguo Dang Dai Er Ke Za Zhi, vol. 25, no. 4, 2023, p. 374, https://doi.org/10.7499/j.issn.1008-8830.2210114.